Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Glaucoma: Overview01:25

Glaucoma: Overview

Glaucoma is an eye condition characterized by increased intraocular pressure that damages the retina and optic nerve, leading to irreversible blindness if left untreated. The human eye has various components, including the cornea, iris, pupil, lens, and optic nerve. Aqueous humor is secreted by the epithelium of the ciliary body in the posterior chamber and flows through the trabecular meshwork and canal of Schlemm, maintaining normal intraocular pressure. The trabecular meshwork and the canal...
Open Angle Glaucoma: Treatment01:27

Open Angle Glaucoma: Treatment

In open-angle glaucoma, the iridocorneal angle remains open, but the trabecular meshwork becomes stiff, slowing down the outflow of aqueous humor. This causes a buildup of aqueous humor in the anterior chamber, leading to a sudden increase in intraocular pressure. The treatment for open-angle glaucoma focuses on reducing the elevated intraocular pressure by either decreasing the secretion of aqueous humor or increasing its outflow.
Drugs such as carbonic anhydrase inhibitors, α2- and...
Angle Closure Glaucoma: Treatment01:28

Angle Closure Glaucoma: Treatment

Angle-closure glaucoma, or closed-angle glaucoma, is an eye condition where the iris bulges out and blocks the iridocorneal angle, resulting in a buildup of aqueous humor and increased intraocular pressure. Immediate medical attention is necessary due to the sudden onset of symptoms. The treatment for angle-closure glaucoma includes short-term and long-term approaches. Short-term treatment involves using eye drops like pilocarpine to lower intraocular pressure by increasing aqueous humor...
Photoreceptors and Visual Pathways01:22

Photoreceptors and Visual Pathways

At the molecular level, visual signals trigger transformations in photopigment molecules, resulting in changes in the photoreceptor cell's membrane potential. The photon's energy level is denoted by its wavelength, with each specific wavelength of visible light associated with a distinct color. The spectral range of visible light, classified as electromagnetic radiation, spans from 380 to 720 nm. Electromagnetic radiation wavelengths exceeding 720 nm fall under the infrared category, whereas...

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Protective role of cyanidin-3-O-glucoside in 2-amino-3-methylimidazo[4,5-f]quinoline-induced gastrointestinal injury: focus on oxidative stress, inflammation, intestinal barrier and gut microbiota.

Journal of the science of food and agriculture·2026
Same author

Wafer-Level Transfer of GaN-on-Si Light-Emitting Devices via SiO<sub>2</sub>-SiO<sub>2</sub> Direct Bonding: Strain Evolution and Optoelectronic Performance.

Micromachines·2026
Same author

Moxibustion for gastrointestinal cancer-related fatigue: study protocol for a randomized clinical trial.

Frontiers in psychiatry·2026
Same author

Distal Vessel Diameter and Antegrade Crossing Success in Chronic Total Occlusion Percutaneous Coronary Intervention.

CJC open·2026
Same author

Placental DNA methylation as a mediator in the association between maternal prenatal bisphenol analogue exposure and myopia in children: A long-term prospective cohort study.

Environmental research·2026
Same author

Dual-Modal Chicken Mortality Detection Using Dynamic Hybrid Convolution-Based Feature Fusion.

Animals : an open access journal from MDPI·2026

Related Experiment Video

Updated: May 22, 2026

Laser-Induced Chronic Ocular Hypertension Model on SD Rats
06:34

Laser-Induced Chronic Ocular Hypertension Model on SD Rats

Published on: December 4, 2007

Cod liver oil: a potential protective supplement for human glaucoma.

Wen-Bin Huang1, Qian Fan, Xiu-Lan Zhang

  • 1Zhongshan Ophthalmic Center, State Key Laboratory of Ophthalmology, Sun Yat-sen University, Guangzhou 510060, Guangdong Province, China.

International Journal of Ophthalmology
|May 4, 2012
PubMed
Summary

Cod liver oil, rich in vitamin A and omega-3 fatty acids, shows potential for treating glaucoma by reducing intraocular pressure and oxidative stress. Further research is needed to confirm its therapeutic benefits for vision health.

Keywords:
cod liver oilglaucomaomega-3 fatty acidsvitamin A

More Related Videos

Experimental Glaucoma Induced by Ocular Injection of Magnetic Microspheres
06:35

Experimental Glaucoma Induced by Ocular Injection of Magnetic Microspheres

Published on: February 2, 2015

Full-Circle Cauterization of Limbal Vascular Plexus for Surgically Induced Glaucoma in Rodents
10:10

Full-Circle Cauterization of Limbal Vascular Plexus for Surgically Induced Glaucoma in Rodents

Published on: February 15, 2022

Related Experiment Videos

Last Updated: May 22, 2026

Laser-Induced Chronic Ocular Hypertension Model on SD Rats
06:34

Laser-Induced Chronic Ocular Hypertension Model on SD Rats

Published on: December 4, 2007

Experimental Glaucoma Induced by Ocular Injection of Magnetic Microspheres
06:35

Experimental Glaucoma Induced by Ocular Injection of Magnetic Microspheres

Published on: February 2, 2015

Full-Circle Cauterization of Limbal Vascular Plexus for Surgically Induced Glaucoma in Rodents
10:10

Full-Circle Cauterization of Limbal Vascular Plexus for Surgically Induced Glaucoma in Rodents

Published on: February 15, 2022

Area of Science:

  • Ophthalmology
  • Nutritional Science
  • Pharmacology

Background:

  • Glaucoma is a leading cause of irreversible blindness.
  • Elevated intraocular pressure (IOP), oxidative stress, and vascular insufficiency are key glaucoma risk factors.
  • Natural compounds and nutritional therapies are being explored for glaucoma management.

Purpose of the Study:

  • To investigate the potential therapeutic benefits of cod liver oil for glaucoma treatment.
  • To evaluate the combined effects of vitamin A and omega-3 polyunsaturated fatty acids (PUFAs) in cod liver oil on glaucoma pathogenesis.

Main Methods:

  • Review of existing literature on glaucoma, vitamin A, omega-3 PUFAs, and cod liver oil.
  • Analysis of the proposed mechanisms by which these components may impact glaucoma progression.

Main Results:

  • Vitamin A acts as an antioxidant, protects ocular surface integrity, and preserves vision.
  • Omega-3 PUFAs are known to decrease IOP, enhance ocular blood flow, and provide neuroprotection.
  • Cod liver oil combines these beneficial components, suggesting a synergistic effect.

Conclusions:

  • Cod liver oil, due to its vitamin A and omega-3 PUFA content, is proposed as a potentially beneficial nutritional supplement for glaucoma.
  • Further clinical studies are warranted to establish the efficacy and safety of cod liver oil in glaucoma management.